Navigation Links
Sequoia Pharmaceuticals Announces Appointment of Steven D. Skolsky as Chief Executive Officer
Date:10/29/2007

GAITHERSBURG, Md., Oct. 29 /PRNewswire/ -- Sequoia Pharmaceuticals, Inc., which discovers and develops novel antiviral therapeutics as well as pharmacokinetic enhancers, announced today the appointment of Steven D. Skolsky as its President and Chief Executive Officer. He will also serve as a member of the Board of Directors.

"Sequoia is pleased to have recruited such an outstanding, talented leader as Steven Skolsky," said Chris Mirabelli, Chairman of the Board of Sequoia Pharmaceuticals. "Steve has an impressive record of success within the pharmaceutical industry. The combination of his leadership and management experience, as well as his business acumen, makes Steve uniquely qualified to lead us through the exciting times ahead."

"Sequoia possesses an extraordinary scientific pedigree, and a very attractive research portfolio. I am honored to have the opportunity to lead Sequoia, and to build on its outstanding technological progress as we move towards commercialization", said Mr. Skolsky.

Mr. Skolsky brings over twenty-five years of U.S. and international experience in the pharmaceutical and biotechnology arena. He most recently served as chief executive officer of Trimeris, a biotechnology company specializing in HIV therapeutics. Previously Mr. Skolsky had a distinguished career at GlaxoSmithKline where he served as GSK's Senior Vice President of Global Commercial Strategy responsible for world-wide clinical development and product strategy. He also served as managing director of GSK's operations in Australia and New Zealand and previously was Vice President of Sales and Marketing of the HIV/Oncology Division at Glaxo Wellcome. He is a graduate of the University of North Carolina at Chapel Hill.

About Sequoia Pharmaceuticals, Inc.

Sequoia Pharmaceuticals discovers and develops revolutionary new treatments, primarily for viral diseases including HIV/AIDS and HCV-induced hepatitis. In addition, Sequoia has an active R&D program in pharmacokinetic enhancers.


'/>"/>
SOURCE Sequoia Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Supply of Radiopharmaceuticals Hampered by Attacks
2. FDA approves Watson Pharmaceuticals Oxytrol patch
3. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
4. Antigenics Pharmaceuticals plans for Phase III trial of its Melanoma vaccine
5. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
6. Top Pharmaceuticals Influence Doctors Prescriptions
7. More Study On Side Effects of ADHD Drug Needed: Shire Pharmaceuticals
8. Personalized Medicine and Innovative Pharmaceuticals
9. New lease of life for asthmatics by Accentia Biopharmaceuticals
10. Pravastatin Launched by Watson Pharmaceuticals
11. Tata Industries picks up stake in Indigene Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... ... March 24, 2017 , ... ... soil, dredged material, and hazardous and non-hazardous materials announced today the acquisition of ... This acquisition will add four additional processing facilities and a vast array of ...
(Date:3/24/2017)... , ... March 24, 2017 , ... ... third world countries to hospitals in the United States, it’s a threat that ... the current obstacles facing infection prevention and offers strategies for the healthcare community ...
(Date:3/24/2017)... ... March 24, 2017 , ... According to a new study by ... it does not obey the rules Congress has directed the CBO to follow. The ... GOP reform would restore. Yet, it estimates a reduction in employer-based coverage due to ...
(Date:3/24/2017)... Lake Orion, MI (PRWEB) , ... March 24, ... ... providing insurance assistance, financial planning, and related services to families and business owners ... charity initiative aimed at feeding regional families struggling with financial difficulties. , The ...
(Date:3/24/2017)... ... March 24, 2017 , ... As ... to create a communications platform that positions them as the go-to thought leader ... reinvented their online publication as an always-on, always-fresh news, views and advocacy engine, ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... -- HealthMine surveys with 9,250 insured consumers fielded from February ... want help from their plans in five key areas: ... 2) help closing gaps in care, 3) better digital ... relevant, real-time guidance. Meeting these needs is essential to ... A Reason to Stay Engaged in Health ...
(Date:3/23/2017)... Mar 23, 2017 Research and Markets has ... Trends - Industry Forecast to 2025" report to their offering. ... The Global ... 6.9% over the next decade to reach approximately $3.5 billion by ... forecasts for all the given segments on global as well as ...
(Date:3/23/2017)... March 23, 2017 ... created through extensive primary research (inputs from industry ... aims to present the analysis of global heart ... (Replacement and Repair); Replacement Procedure By Technique (Mechanical, ... Technique (Surgical Devices, Balloon Valvuloplasty, Transcatheter Mitral Valve ...
Breaking Medicine Technology: